Axsome Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC AXSM

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

402,700

Value ($000)

73,549

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	73,549	0.0%	402,700	12/31/2025
2025 Q3	11/10/2025	46,400	0.0%	382,047	9/30/2025
2025 Q2	8/12/2025	37,231	0.0%	356,651	6/30/2025
2025 Q1	9/15/2025	39,333	0.0%	337,246	3/31/2025
2024 Q4	2/6/2025	27,755	0.0%	328,034	12/31/2024
2024 Q3	11/12/2024	28,992	0.0%	322,596	9/30/2024
2024 Q2	8/12/2024	24,940	0.0%	309,818	6/30/2024
2024 Q1	5/9/2024	24,026	0.0%	301,074	3/31/2024
2023 Q4	2/6/2024	23,535	0.0%	295,701	12/31/2023
2023 Q3	11/8/2023	20,259	0.0%	289,871	9/30/2023
2023 Q2	8/10/2023	19,288	0.0%	268,414	6/30/2023
2023 Q1	5/12/2023	15,366	0.0%	249,118	3/31/2023
2022 Q4	2/13/2023	19,265	0.0%	249,770	12/31/2022
2022 Q3	11/14/2022	10,100	0.0%	226,353	9/30/2022
2022 Q2	8/15/2022	8,208	0.0%	214,286	6/30/2022
2022 Q1	5/13/2022	8,825	0.0%	213,213	3/31/2022
2021 Q4	2/11/2022	7,830	0.0%	207,230	12/31/2021
2021 Q3	11/16/2021	6,726	0.0%	204,052	9/30/2021
2021 Q2	8/16/2021	12,554	0.0%	186,095	6/30/2021
2021 Q1	5/17/2021	10,353	0.0%	182,842	3/31/2021
2020 Q4	2/16/2021	14,442	0.0%	177,267	12/31/2020
2020 Q3	11/13/2020	12,499	0.0%	175,413	9/30/2020
2020 Q2	8/20/2020	14,896	0.0%	181,040	6/30/2020
2020 Q1	5/15/2020	9,874	0.0%	167,830	3/31/2020
2019 Q4	2/7/2020	16,556	0.0%	160,178	12/31/2019